[ad_1]
“The worst is when it comes to politicizing vaccine problems.
It is clear that the European Medicines Agency must approve the safety, efficacy and quality of the Sputnik vaccine, and then we must think about how to guarantee vaccination throughout the world, including the entire European region, which includes 53 countries. .
According to him, for the COVID-19 vaccination process to be smooth, as many safe and effective vaccines as possible should be used.
Human lives are the most important value and everything else is already secondary.
“Be it AstraZeneca, Sputnik or Pfizer, etc.”, added the Social Democrat. “The threat of a pandemic is enormous and human lives are the most important value, and everything else is already secondary.”
Conservative Matas Maldeikis, a spokesman for the ruling conference, predicted there would be a lot of discussion on this issue.
“I imagine there will be a great debate here, this issue will definitely not only be medical, but also political, and it will definitely have a lot of resonance,” he said.
Photo by Luke April / 15 minutes / Matas Maldeikis
Earlier Tuesday, both Prime Minister Ingrida Šimonytė and the President’s Senior Adviser for Foreign Affairs, Asta Skaisgirytė, said that Lithuania would not vaccinate its population with Western vaccines and would not purchase the Russian Sputnik V, even if it was approved by the European Agency. of Medicines.
According to I. Šimonytė, the Russian government uses this vaccine for geopolitical purposes.
Recently, Sputnik V vaccines Hungary has approved its use.
“Scanpix” / “PA Wire” / “Press Association Images” nuotr./ “Sputnik V” vakcina
The country also approved the use of the Chinese-made COVID-19 vaccine, pending a joint decision by the European Union.
German and French leaders also do not rule out the availability of Russian and Chinese vaccines, but are still awaiting a decision from the European Medicines Agency.
The Sputnik V vaccine was initially criticized for its haste and lack of transparent information.
However, a comprehensive study by Russian scientists recently appeared in the British scientific journal Lancet, the results of which are beyond question.
It is reported here that the effectiveness of the Russian vaccine, based on clinical trials, is 91%, and those still infected with COVID-19 are more likely to become ill after vaccination.
More about the study and the Sputnik V vaccine against COVID-19 – here.
[ad_2]
